Dr. Paul Sax discusses the latest treatment strategies for bacteremia due to MRSA in the latest
HIV and ID Observations.
Bacteremia due to methicillin-resistant Staphylococcus aureus is no easy task, admits Dr. Paul Sax. In the latest HIV and ID Observations blog post, he examines two new clinical trials that help to move the field forward.
Want to see more from NEJM Journal Watch? Register here.